Osberger Thomas J, Rogness Donald C, Kohrt Jeffrey T, Stepan Antonia F, White M Christina
Department of Chemistry, Roger Adams Laboratory, University of Illinois, Urbana, Illinois 61801, USA.
Pfizer Worldwide Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, USA.
Nature. 2016 Sep 8;537(7619):214-219. doi: 10.1038/nature18941. Epub 2016 Aug 1.
Secondary metabolites synthesized by non-ribosomal peptide synthetases display diverse and complex topologies and possess a range of biological activities. Much of this diversity derives from a synthetic strategy that entails pre- and post-assembly oxidation of both the chiral amino acid building blocks and the assembled peptide scaffolds. The vancomycin biosynthetic pathway is an excellent example of the range of oxidative transformations that can be performed by the iron-containing enzymes involved in its biosynthesis. However, because of the challenges associated with using such oxidative enzymes to carry out chemical transformations in vitro, chemical syntheses guided by these principles have not been fully realized in the laboratory. Here we report that two small-molecule iron catalysts are capable of facilitating the targeted C-H oxidative modification of amino acids and peptides with preservation of α-centre chirality. Oxidation of proline to 5-hydroxyproline furnishes a versatile intermediate that can be transformed to rigid arylated derivatives or flexible linear carboxylic acids, alcohols, olefins and amines in both monomer and peptide settings. The value of this C-H oxidation strategy is demonstrated in its capacity for generating diversity: four 'chiral pool' amino acids are transformed to twenty-one chiral unnatural amino acids representing seven distinct functional group arrays; late-stage C-H functionalizations of a single proline-containing tripeptide furnish eight tripeptides, each having different unnatural amino acids. Additionally, a macrocyclic peptide containing a proline turn element is transformed via late-stage C-H oxidation to one containing a linear unnatural amino acid.
由非核糖体肽合成酶合成的次生代谢产物具有多样而复杂的拓扑结构,并拥有一系列生物活性。这种多样性很大程度上源于一种合成策略,该策略涉及手性氨基酸构建单元和组装后的肽支架的组装前和组装后氧化。万古霉素生物合成途径是参与其生物合成的含铁酶可进行的氧化转化范围的一个绝佳例子。然而,由于在体外使用此类氧化酶进行化学转化存在挑战,基于这些原理的化学合成在实验室中尚未完全实现。在此我们报告,两种小分子铁催化剂能够促进氨基酸和肽的靶向C-H氧化修饰,同时保留α中心手性。脯氨酸氧化为5-羟脯氨酸可提供一种通用中间体,该中间体在单体和肽环境中均可转化为刚性芳基化衍生物或柔性线性羧酸、醇、烯烃和胺。这种C-H氧化策略的价值体现在其产生多样性的能力上:四种“手性池”氨基酸被转化为代表七种不同官能团阵列的二十一种手性非天然氨基酸;单个含脯氨酸三肽的后期C-H官能化产生八种三肽,每种都含有不同的非天然氨基酸。此外,含有脯氨酸转角元件的大环肽通过后期C-H氧化转化为含有线性非天然氨基酸的大环肽。